Updated Efficacy and Safety from the Phase 3 Resonate-2 Study: Ibrutinib As First-Line Treatment Option in Patients 65 Years and Older with Chronic Lymphocytic Leukemia/Small Lymphocytic Leukemia
| Image |  |
|---|---|
| Description | Scientific article published on 2 Dec 2016 |
| Author/s |
author: Fritz Offner Lori Styles Osnat Bairey Danelle F James Paul M Barr Jan A Burger Nancy L Bartlett Cathy Zhou Steven Coutre Sebastian Grosicki Alessandra Tedeschi Tadeusz Robak Carol Moreno Thomas J Kipps Peter Hillmen Stephen Devereux David Simpson Paolo Ghia |
| Publication date | December 2, 2016 |
| Language | English |
| Country of origin | |
| Wikipedia link | |
| Copyright status | |
| Missing/wrong data? | Edit Wikidata item |